Yujiao Zhang

Publication Activity (10 Years)

Years Active: 2018-2023
Publications (10 Years): 5

Top Topics

Endoplasmic Reticulum Stress

Cancer Stem Cells

Atomic Force Microscopy

Cell Cycle Arrest

Top Venues

Journal of breast cancer

Cell cycle (Georgetown, Tex.)

This page only lists publications with an associated author ORCID identifier.

Publications

Yujiao Zhang, Xizhi Liu, Wenhui Dang, Lu Liu
Thymoquinone inhibits lung cancer stem cell properties via triggering YAP degradation. Carcinogenesis (2023)
Anqi Luo, Min Meng, Guanying Wang, Rui Han, Yujiao Zhang, Xin Jing, Lin Zhao, Shanzhi Gu, Xinhan Zhao
Corrigendum: Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling. Journal of breast cancer 23 (5) (2020)
Anqi Luo, Min Meng, Guanying Wang, Rui Han, Yujiao Zhang, Xin Jing, Lin Zhao, Shanzhi Gu, Xinhan Zhao
Myeloid-Derived Suppressor Cells Recruited by Chemokine (C-C Motif) Ligand 3 Promote the Progression of Breast Cancer via Phosphoinositide 3-Kinase-Protein Kinase B-Mammalian Target of Rapamycin Signaling. Journal of breast cancer 23 (2) (2020)
Yu Zhou, Yan Geng, Yujiao Zhang, Yubin Zhou, Chen Chu, Samanta Sharma, Anne Fassl, Deborah Butter, Piotr Sicinski
The requirement for cyclin E in c-Myc overexpressing breast cancers. Cell cycle (Georgetown, Tex.) 19 (20) (2020)
Yujiao Zhang, Yizeng Fan, Shangke Huang, Guanying Wang, Rui Han, Fuxi Lei, Anqi Luo, Xin Jing, Lin Zhao, Shanzhi Gu, Xinhan Zhao
Thymoquinone inhibits the metastasis of renal cell cancer cells by inducing autophagy via AMPK/mTOR signaling pathway. Cancer science 109 (12) (2018)